©The Author(s) 2025.
World J Virol. Sep 25, 2025; 14(3): 108405
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.108405
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.108405
Table 3 Treatment and management strategies for Lassa fever
| Component | Objective | Key interventions |
| Antiviral therapy | Inhibit viral replication | Intravenous ribavirin (ideally within first 6 days); oral ribavirin for mild or remote settings |
| Supportive care | Stabilize and support vital functions | Intravenous fluids and electrolyte balance; nutritional support; oxygen therapy; antipyretics; blood transfusions |
| Severe case management | Manage complications and prevent multiorgan failure | Antibiotics for secondary infections; dialysis for renal failure; ventilation support; seizure control |
| Pregnancy-specific care | Reduce maternal and fetal mortality | Specialized obstetric care; consider therapeutic abortion in advanced pregnancy with severe infection |
| Post-recovery care | Promote long-term recovery and quality of life | Audiology screening and support; psychological counseling; physical rehabilitation and follow-up |
- Citation: Uppala PK, Karanam SK, Kandra NV, Edhi S. Lassa fever: A comprehensive review of virology, clinical management, and global health implications. World J Virol 2025; 14(3): 108405
- URL: https://www.wjgnet.com/2220-3249/full/v14/i3/108405.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i3.108405